Orchid Chemicals & Pharmaceuticals Ltd - Product Pipeline Review - 2014

Published: Jul, 2014 | Pages: 47 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Orchid Chemicals & Pharmaceuticals Ltd - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'Orchid Chemicals & Pharmaceuticals Ltd - Product Pipeline Review - 2014', provides an overview of the Orchid Chemicals & Pharmaceuticals Ltd's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Orchid Chemicals & Pharmaceuticals Ltd's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Orchid Chemicals & Pharmaceuticals Ltd including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Orchid Chemicals & Pharmaceuticals Ltd's human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Orchid Chemicals & Pharmaceuticals Ltd's pipeline products

Reasons to buy

- Evaluate Orchid Chemicals & Pharmaceuticals Ltd's strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Orchid Chemicals & Pharmaceuticals Ltd in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Orchid Chemicals & Pharmaceuticals Ltd's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Orchid Chemicals & Pharmaceuticals Ltd and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Orchid Chemicals & Pharmaceuticals Ltd
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Orchid Chemicals & Pharmaceuticals Ltd and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

 Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 5
Orchid Chemicals & Pharmaceuticals Ltd Snapshot 6
Orchid Chemicals & Pharmaceuticals Ltd Overview 6
Key Information 6
Key Facts 6
Orchid Chemicals & Pharmaceuticals Ltd - Research and Development Overview 7
Key Therapeutic Areas 7
Orchid Chemicals & Pharmaceuticals Ltd - Pipeline Review 10
Pipeline Products by Stage of Development 10
Pipeline Products - Monotherapy 11
Pipeline Products - Partnered Products 12
Partnered Products/Combination Treatment Modalities 13
Orchid Chemicals & Pharmaceuticals Ltd - Pipeline Products Glance 14
Orchid Chemicals & Pharmaceuticals Ltd - Clinical Stage Pipeline Products 14
Phase I Products/Combination Treatment Modalities 14
Orchid Chemicals & Pharmaceuticals Ltd - Early Stage Pipeline Products 15
Preclinical Products/Combination Treatment Modalities 15
Discovery Products/Combination Treatment Modalities 16
Orchid Chemicals & Pharmaceuticals Ltd - Drug Profiles 17
OCID-4681 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
OCID-0050 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
OCID-2987 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
OCID-5005 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
OCID-5090 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
Small Molecule to Inhibit Dipeptidyl-Peptidase IV for Type 2 Diabetes 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
Small Molecule to Inhibit IL-6 and STAT3 for Oncology 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
Small Molecule to Inhibit Th1/Th2 Cytokine Synthase for Inflammation 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
Small Molecule to Inhibit TNF Alpha for Inflammation 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
tubastatin 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
cephalosporin 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
Small Molecule 1 to Inhibit HDAC for Oncology 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
Small Molecule 2 to Inhibit HDAC for Oncology 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
Small Molecule 3 to Inhibit HDAC for Oncology 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
Small Molecule for Central Nervous System 32
Product Description 32
Mechanism of Action 32
R&D Progress 32
Small Molecule for Diabetes 33
Product Description 33
Mechanism of Action 33
R&D Progress 33
Small Molecule for Obesity 34
Product Description 34
Mechanism of Action 34
R&D Progress 34
Small Molecule to Antagonize ALK for Lung Cancer 35
Product Description 35
Mechanism of Action 35
R&D Progress 35
Small Molecules for Tuberculosis 36
Product Description 36
Mechanism of Action 36
R&D Progress 36
Orchid Chemicals & Pharmaceuticals Ltd - Pipeline Analysis 37
Orchid Chemicals & Pharmaceuticals Ltd - Pipeline Products by Target 37
Orchid Chemicals & Pharmaceuticals Ltd - Pipeline Products by Route of Administration 39
Orchid Chemicals & Pharmaceuticals Ltd - Pipeline Products by Molecule Type 40
Orchid Chemicals & Pharmaceuticals Ltd - Pipeline Products by Mechanism of Action 41
Orchid Chemicals & Pharmaceuticals Ltd - Dormant Projects 43
Orchid Chemicals & Pharmaceuticals Ltd - Locations And Subsidiaries 44
Head Office 44
Other Locations & Subsidiaries 44
Appendix 46
Methodology 46
Coverage 46
Secondary Research 46
Primary Research 46
Expert Panel Validation 46
Contact Us 47
Disclaimer 47

List of Tables
Orchid Chemicals & Pharmaceuticals Ltd, Key Information 6
Orchid Chemicals & Pharmaceuticals Ltd, Key Facts 6
Orchid Chemicals & Pharmaceuticals Ltd - Pipeline by Indication, 2014 9
Orchid Chemicals & Pharmaceuticals Ltd - Pipeline by Stage of Development, 2014 10
Orchid Chemicals & Pharmaceuticals Ltd - Monotherapy Products in Pipeline, 2014 11
Orchid Chemicals & Pharmaceuticals Ltd - Partnered Products in Pipeline, 2014 12
Orchid Chemicals & Pharmaceuticals Ltd - Partnered Products/ Combination Treatment Modalities, 2014 13
Orchid Chemicals & Pharmaceuticals Ltd - Phase I, 2014 14
Orchid Chemicals & Pharmaceuticals Ltd - Preclinical, 2014 15
Orchid Chemicals & Pharmaceuticals Ltd - Discovery, 2014 16
Orchid Chemicals & Pharmaceuticals Ltd - Pipeline by Target, 2014 38
Orchid Chemicals & Pharmaceuticals Ltd - Pipeline by Route of Administration, 2014 39
Orchid Chemicals & Pharmaceuticals Ltd - Pipeline by Molecule Type, 2014 40
Orchid Chemicals & Pharmaceuticals Ltd - Pipeline Products by Mechanism of Action, 2014 42
Orchid Chemicals & Pharmaceuticals Ltd - Dormant Developmental Projects,2014 43
Orchid Chemicals & Pharmaceuticals Ltd, Other Locations 44
Orchid Chemicals & Pharmaceuticals Ltd, Subsidiaries 45